相似文献
1
Effector and regulatory B cells: modulators of CD4+ T cell immunity.
Nat Rev Immunol. 2010 Apr;10(4):236-47. doi: 10.1038/nri2729. Epub 2010 Mar 12.
2
Regulatory B cells as inhibitors of immune responses and inflammation.
Immunol Rev. 2008 Aug;224:201-14. doi: 10.1111/j.1600-065X.2008.00661.x.
3
Gene profiling of CD11b⁺ and CD11b⁻ B1 cell subsets reveals potential cell sorting artifacts.
J Exp Med. 2012 Mar 12;209(3):433-4. doi: 10.1084/jem.20120402.
4
Extrafollicular CD4 T cell-derived IL-10 functions rapidly and transiently to support anti-Plasmodium humoral immunity.
PLoS Pathog. 2021 Feb 2;17(2):e1009288. doi: 10.1371/journal.ppat.1009288. eCollection 2021 Feb.
5
B cells induced by Schistosoma japonicum infection display diverse regulatory phenotypes and modulate CD4 T cell response.
Parasit Vectors. 2020 Mar 20;13(1):147. doi: 10.1186/s13071-020-04015-3.
6
Hypoxia-inducible factors in CD4 T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity.
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8975-8984. doi: 10.1073/pnas.1811702116. Epub 2019 Apr 15.
7
New insights into cathelicidin modulation of adaptive immunity.
Eur J Immunol. 2011 Oct;41(10):2817-9. doi: 10.1002/eji.201142055.
8
Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets.
Eur J Immunol. 2013 Jul;43(7):1818-27. doi: 10.1002/eji.201242784. Epub 2013 May 8.
9
B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.
J Immunol. 2010 Apr 1;184(7):4006-16. doi: 10.4049/jimmunol.0903009. Epub 2010 Mar 1.
10
Immune complex-mediated enhancement of secondary antibody responses.
J Immunol. 2010 Jun 1;184(11):6293-8. doi: 10.4049/jimmunol.0902530. Epub 2010 May 3.
引用本文的文献
1
The role of B lymphocyte subsets in nephrotic syndrome: functions, mechanisms, clinical significance and future perspectives.
Front Immunol. 2025 Aug 7;16:1598197. doi: 10.3389/fimmu.2025.1598197. eCollection 2025.
2
B-cell subsets in leprosy lesions: unraveling the complex interplay.
An Bras Dermatol. 2025 Aug 9;100(5):501184. doi: 10.1016/j.abd.2025.501184.
3
Stromal senescence contributes to age-related increases in cancer.
Nat Rev Cancer. 2025 Aug 4. doi: 10.1038/s41568-025-00840-9.
4
The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review.
Stem Cell Res Ther. 2025 Jun 17;16(1):308. doi: 10.1186/s13287-025-04431-1.
5
Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression.
Front Immunol. 2025 May 29;16:1595070. doi: 10.3389/fimmu.2025.1595070. eCollection 2025.
6
Blocking plasma cell fate enhances antigen-specific presentation by B cells to boost anti-tumor immunity.
Nat Commun. 2025 May 14;16(1):4454. doi: 10.1038/s41467-025-59622-4.
7
Sex Differences in Lung B Cell Responses in a Murine Model of Asthma.
Int Arch Allergy Immunol. 2025 Apr 29:1-12. doi: 10.1159/000546024.
8
Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells.
Cells. 2025 Apr 17;14(8):606. doi: 10.3390/cells14080606.
9
Transitional and CD21 PD-1 B cells are associated with remission in early rheumatoid arthritis.
BMC Rheumatol. 2025 Apr 21;9(1):45. doi: 10.1186/s41927-025-00487-x.
10
Night-Time Chronotherapy with Methylprednisolone Prevents an Acute Rejection in Pediatric Patients with Liver Transplantation: A Randomized Clinical Trial.
Clin Pharmacol Ther. 2025 Aug;118(2):386-393. doi: 10.1002/cpt.3640. Epub 2025 Mar 16.
本文引用的文献
1
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
N Engl J Med. 2009 Nov 26;361(22):2143-52. doi: 10.1056/NEJMoa0904452.
2
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis.
Autoimmun Rev. 2009 Dec;9(2):82-9. doi: 10.1016/j.autrev.2009.08.007. Epub 2009 Aug 27.
3
Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application.
J Immunol. 2009 Sep 15;183(6):4094-102. doi: 10.4049/jimmunol.0901081. Epub 2009 Aug 14.
4
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.
Clin Exp Immunol. 2009 Aug;157(2):198-208. doi: 10.1111/j.1365-2249.2009.03979.x.
5
B-cell-depleting induction therapy and acute cellular rejection.
N Engl J Med. 2009 Jun 18;360(25):2683-5. doi: 10.1056/NEJMc0808481.
6
The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.
J Immunol. 2009 Jun 15;182(12):7459-72. doi: 10.4049/jimmunol.0900270.
7
CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.
Diabetes. 2009 Jul;58(7):1568-77. doi: 10.2337/db08-1504. Epub 2009 Mar 31.
8
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.
J Immunol. 2009 Mar 15;182(6):3492-3502. doi: 10.4049/jimmunol.0803052.
9
Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus.
Immunity. 2009 Mar 20;30(3):421-33. doi: 10.1016/j.immuni.2009.01.006. Epub 2009 Feb 26.
10
Requirement of B cells for generating CD4+ T cell memory.
J Immunol. 2009 Feb 15;182(4):1868-76. doi: 10.4049/jimmunol.0802501.
Zotero 插件